Onconetix, Inc. Files 8-K on Shareholder Votes and Financials

Ticker: ONCO · Form: 8-K · Filed: 2025-06-05T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, financials, filing-update

Related Tickers: ONCO

TL;DR

Onconetix (ONCO) filed an 8-K on May 30th covering shareholder votes and financials.

AI Summary

Onconetix, Inc. filed an 8-K on June 5, 2025, reporting on matters submitted to a vote of security holders and financial statements as of May 30, 2025. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio.

Why It Matters

This filing provides an update on corporate governance and financial status, which is crucial for investors to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.

Key Players & Entities

Onconetix, Inc. (company) — Registrant
Blue Water Biotech, Inc. (company) — Former company name
Blue Water Vaccines Inc. (company) — Former company name
May 30, 2025 (date) — Date of earliest event reported
June 5, 2025 (date) — Date of report

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.

What is the exact date of the financial statements being reported?

The filing states that the financial statements are as of May 30, 2025.

When was Onconetix, Inc. previously known as Blue Water Biotech, Inc. and when did the name change occur?

The company was formerly known as Blue Water Biotech, Inc., and the date of that name change was April 24, 2023.

What is the principal executive office address of Onconetix, Inc.?

The principal executive offices are located at 201 E. Fifth Street, Suite 1900, Cincinnati, Ohio 45202.

What is the SIC code for Onconetix, Inc.?

The Standard Industrial Classification (SIC) code for Onconetix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0001213900-25-051573.txt : 20250605 0001213900-25-051573.hdr.sgml : 20250605 20250605161258 ACCESSION NUMBER: 0001213900-25-051573 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250530 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250605 DATE AS OF CHANGE: 20250605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onconetix, Inc. CENTRAL INDEX KEY: 0001782107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41294 FILM NUMBER: 251027243 BUSINESS ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 513-620-4101 MAIL ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Biotech, Inc. DATE OF NAME CHANGE: 20230424 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Vaccines Inc. DATE OF NAME CHANGE: 20190710 8-K 1 ea0244883-8k_onconetix.htm CURRENT REPORT false 0001782107 0001782107 2025-05-30 2025-05-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of report (Date of earliest event reported): May 30, 2025   Onconetix, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-41294   83-2262816 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   201 E. Fifth Street , Suite 1900 Cincinnati , Ohio   45202 (Address of principal executive offices)   (Zip Code)   Registrant’s telephone number, including area code: ( 513 ) 620-4101   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.00001 per share   ONCO   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 5.07 Submission of Matters to a Vote of Security Holders.   On May 30, 2025, Onconetix, Inc. (the “Company”) held its 2025 special meeting of stockholders (the “Special Meeting”). The matters voted on at the Special Meeting were:   (1) To approve and adopt an amendment to the Onconetix, Inc. Amended and Restated Certificate of Incorpor